Skip to main content

Frank Thomas

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Frank Thomas

Frank Thomas is recorded as Chairman at Spero Therapeutics, Inc. (SPRO). Spero Therapeutics, Inc. reported in an 8-K filed January 10, 2025 that Frank Thomas was appointed Chairman of the Board, effective January 7, 2025.

“The Board has appointed director Frank Thomas to serve as the Chairman of the Board, stepping in for Dr. Mahadevia, who continues to serve as a member of the Board for the duration of his directorship term.”
Spero Therapeutics, Inc. Form 8-K, filed January 10, 2025 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Spero Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.